4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001231919-26-000422
10% owner disposed of 1,407,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2026-04-27 | Other disposition | −1,407,000 | 6,475,882 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2026-04-27 | Other acquisition · Pre-Funded Warrants (Right to Buy) | +1,407,000 | 1,407,000 | I: show line 2 in the form |
Loading xslF345X06/form4-04282026_090449.xml…